Reviewing SeaSpine (SPNE) and STRATA Skin Sciences (SSKN)

SeaSpine (NASDAQ:SPNE) and STRATA Skin Sciences (NASDAQ:SSKN) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their risk, analyst recommendations, valuation, institutional ownership, earnings, profitability and dividends.

Risk & Volatility

SeaSpine has a beta of 0.08, indicating that its share price is 92% less volatile than the S&P 500. Comparatively, STRATA Skin Sciences has a beta of 1.25, indicating that its share price is 25% more volatile than the S&P 500.

Analyst Recommendations

This is a summary of current recommendations and price targets for SeaSpine and STRATA Skin Sciences, as reported by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
SeaSpine 0 0 5 0 3.00
STRATA Skin Sciences 0 0 3 0 3.00

SeaSpine presently has a consensus target price of $21.20, indicating a potential upside of 52.19%. STRATA Skin Sciences has a consensus target price of $6.00, indicating a potential upside of 86.92%. Given STRATA Skin Sciences’ higher probable upside, analysts plainly believe STRATA Skin Sciences is more favorable than SeaSpine.

Profitability

This table compares SeaSpine and STRATA Skin Sciences’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
SeaSpine -22.60% -30.81% -23.53%
STRATA Skin Sciences -18.33% -18.83% -12.24%

Earnings & Valuation

This table compares SeaSpine and STRATA Skin Sciences’ revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
SeaSpine $131.81 million 1.96 -$32.11 million ($2.18) -6.39
STRATA Skin Sciences $31.45 million 3.06 -$18.83 million $1.97 1.63

STRATA Skin Sciences has lower revenue, but higher earnings than SeaSpine. SeaSpine is trading at a lower price-to-earnings ratio than STRATA Skin Sciences, indicating that it is currently the more affordable of the two stocks.

Insider & Institutional Ownership

46.3% of SeaSpine shares are owned by institutional investors. Comparatively, 26.8% of STRATA Skin Sciences shares are owned by institutional investors. 13.5% of SeaSpine shares are owned by company insiders. Comparatively, 45.6% of STRATA Skin Sciences shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Summary

STRATA Skin Sciences beats SeaSpine on 10 of the 13 factors compared between the two stocks.

About SeaSpine

SeaSpine Holdings Corporation, a medical technology company, focuses on the design, development, and commercialization of surgical solutions for the treatment of spinal disorders in the United States and internationally. The company provides orthobiologics and spinal implant solutions for the neurosurgeons and orthopedic spine surgeons to perform fusion procedures in the lumbar, thoracic, and cervical regions of the spine. Its orthobiologics products include demineralized bone matrices, collagen ceramic matrices, demineralized cancellous allograft bone products, and synthetic bone void fillers to enhance bone fusion rates in a range of orthopedic surgeries, including spine, hip, and extremities procedures. The company offers orthobiologics products in various forms, such as putties, pastes, strips, and resorbable mesh. Its spinal implant portfolio comprises products for spinal decompression, alignment, and stabilization that are used to facilitate fusion in minimally invasive, complex, deformity, and degenerative procedures. The company was incorporated in 2015 and is headquartered in Carlsbad, California.

About STRATA Skin Sciences

STRATA Skin Sciences, Inc., a medical technology company, focuses on the therapeutic and aesthetic dermatology market. The company operates through three segments: Dermatology Recurring Procedures, Dermatology Procedures Equipment, and Dermatology Imaging. Its products include XTRAC laser and VTRAC excimer lamp systems used for the treatment of psoriasis, vitiligo, and other skin conditions; the STRATAPEN MicroSystems, a micropigmentation device; and Nordlys, a multi-technology aesthetic laser device for treating vascular and pigmented lesions. STRATA Skin Sciences, Inc. was founded in 1989 and is based in Horsham, Pennsylvania.

Receive News & Ratings for SeaSpine Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SeaSpine and related companies with MarketBeat.com's FREE daily email newsletter.



Leave a Reply